An islet in distress: β cell failure in type 2 diabetes

Takeshi Ogihara, Raghu Mirmira

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Over 200 million people worldwide suffer from diabetes, a disorder of glucose homeostasis. The majority of these individuals are diagnosed with type 2 diabetes. It has traditionally been thought that tissue resistance to the action of insulin is the primary defect in type 2 diabetes. However, recent longitudinal and genome-wide association studies have shown that insulin resistance is more likely to be a precondition, and that the failure of the pancreatic β cell to meet the increased insulin requirements is the triggering factor in the development of type 2 diabetes. A major emphasis in diabetes research has therefore shifted to understanding the causes of β cell failure. Collectively, these studies have implicated a complex network of triggers, which activate intersecting execution pathways leading to β cell dysfunction and death. In the present review, we discuss these triggers (glucotoxicity, lipotoxicity, amyloid and cytokines) with respect to the pathways they activate (oxidative stress, inflammation and endoplasmic reticulum stress) and propose a model for understanding β cell failure in type 2 diabetes.

Original languageEnglish
Pages (from-to)123-133
Number of pages11
JournalJournal of Diabetes Investigation
Volume1
Issue number4
DOIs
StatePublished - Aug 2010

Fingerprint

Type 2 Diabetes Mellitus
Insulin
Endoplasmic Reticulum Stress
Genome-Wide Association Study
Amyloid
Insulin Resistance
Oxidative Stress
Homeostasis
Cell Death
Cytokines
Inflammation
Glucose
Research

Keywords

  • Diabetes
  • Insulin resistance
  • Islet

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

An islet in distress : β cell failure in type 2 diabetes. / Ogihara, Takeshi; Mirmira, Raghu.

In: Journal of Diabetes Investigation, Vol. 1, No. 4, 08.2010, p. 123-133.

Research output: Contribution to journalArticle

@article{7974123435c44fb282e89fe52a26d73a,
title = "An islet in distress: β cell failure in type 2 diabetes",
abstract = "Over 200 million people worldwide suffer from diabetes, a disorder of glucose homeostasis. The majority of these individuals are diagnosed with type 2 diabetes. It has traditionally been thought that tissue resistance to the action of insulin is the primary defect in type 2 diabetes. However, recent longitudinal and genome-wide association studies have shown that insulin resistance is more likely to be a precondition, and that the failure of the pancreatic β cell to meet the increased insulin requirements is the triggering factor in the development of type 2 diabetes. A major emphasis in diabetes research has therefore shifted to understanding the causes of β cell failure. Collectively, these studies have implicated a complex network of triggers, which activate intersecting execution pathways leading to β cell dysfunction and death. In the present review, we discuss these triggers (glucotoxicity, lipotoxicity, amyloid and cytokines) with respect to the pathways they activate (oxidative stress, inflammation and endoplasmic reticulum stress) and propose a model for understanding β cell failure in type 2 diabetes.",
keywords = "Diabetes, Insulin resistance, Islet",
author = "Takeshi Ogihara and Raghu Mirmira",
year = "2010",
month = "8",
doi = "10.1111/j.2040-1124.2010.00021.x",
language = "English",
volume = "1",
pages = "123--133",
journal = "Journal of Diabetes Investigation",
issn = "2040-1116",
publisher = "Blackwell Publishing Asia Pty Ltd",
number = "4",

}

TY - JOUR

T1 - An islet in distress

T2 - β cell failure in type 2 diabetes

AU - Ogihara, Takeshi

AU - Mirmira, Raghu

PY - 2010/8

Y1 - 2010/8

N2 - Over 200 million people worldwide suffer from diabetes, a disorder of glucose homeostasis. The majority of these individuals are diagnosed with type 2 diabetes. It has traditionally been thought that tissue resistance to the action of insulin is the primary defect in type 2 diabetes. However, recent longitudinal and genome-wide association studies have shown that insulin resistance is more likely to be a precondition, and that the failure of the pancreatic β cell to meet the increased insulin requirements is the triggering factor in the development of type 2 diabetes. A major emphasis in diabetes research has therefore shifted to understanding the causes of β cell failure. Collectively, these studies have implicated a complex network of triggers, which activate intersecting execution pathways leading to β cell dysfunction and death. In the present review, we discuss these triggers (glucotoxicity, lipotoxicity, amyloid and cytokines) with respect to the pathways they activate (oxidative stress, inflammation and endoplasmic reticulum stress) and propose a model for understanding β cell failure in type 2 diabetes.

AB - Over 200 million people worldwide suffer from diabetes, a disorder of glucose homeostasis. The majority of these individuals are diagnosed with type 2 diabetes. It has traditionally been thought that tissue resistance to the action of insulin is the primary defect in type 2 diabetes. However, recent longitudinal and genome-wide association studies have shown that insulin resistance is more likely to be a precondition, and that the failure of the pancreatic β cell to meet the increased insulin requirements is the triggering factor in the development of type 2 diabetes. A major emphasis in diabetes research has therefore shifted to understanding the causes of β cell failure. Collectively, these studies have implicated a complex network of triggers, which activate intersecting execution pathways leading to β cell dysfunction and death. In the present review, we discuss these triggers (glucotoxicity, lipotoxicity, amyloid and cytokines) with respect to the pathways they activate (oxidative stress, inflammation and endoplasmic reticulum stress) and propose a model for understanding β cell failure in type 2 diabetes.

KW - Diabetes

KW - Insulin resistance

KW - Islet

UR - http://www.scopus.com/inward/record.url?scp=78650073927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650073927&partnerID=8YFLogxK

U2 - 10.1111/j.2040-1124.2010.00021.x

DO - 10.1111/j.2040-1124.2010.00021.x

M3 - Article

AN - SCOPUS:78650073927

VL - 1

SP - 123

EP - 133

JO - Journal of Diabetes Investigation

JF - Journal of Diabetes Investigation

SN - 2040-1116

IS - 4

ER -